全文获取类型
收费全文 | 1881篇 |
免费 | 292篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 88篇 |
妇产科学 | 42篇 |
基础医学 | 309篇 |
口腔科学 | 52篇 |
临床医学 | 240篇 |
内科学 | 276篇 |
皮肤病学 | 81篇 |
神经病学 | 174篇 |
特种医学 | 48篇 |
外科学 | 317篇 |
综合类 | 22篇 |
现状与发展 | 1篇 |
一般理论 | 2篇 |
预防医学 | 168篇 |
眼科学 | 75篇 |
药学 | 74篇 |
中国医学 | 3篇 |
肿瘤学 | 195篇 |
出版年
2023年 | 21篇 |
2022年 | 20篇 |
2021年 | 36篇 |
2020年 | 32篇 |
2019年 | 24篇 |
2018年 | 60篇 |
2017年 | 51篇 |
2016年 | 62篇 |
2015年 | 67篇 |
2014年 | 76篇 |
2013年 | 106篇 |
2012年 | 93篇 |
2011年 | 112篇 |
2010年 | 86篇 |
2009年 | 107篇 |
2008年 | 83篇 |
2007年 | 89篇 |
2006年 | 91篇 |
2005年 | 82篇 |
2004年 | 68篇 |
2003年 | 68篇 |
2002年 | 68篇 |
2001年 | 34篇 |
2000年 | 37篇 |
1999年 | 49篇 |
1998年 | 40篇 |
1997年 | 33篇 |
1996年 | 37篇 |
1995年 | 31篇 |
1994年 | 23篇 |
1993年 | 14篇 |
1992年 | 25篇 |
1991年 | 11篇 |
1990年 | 16篇 |
1989年 | 24篇 |
1988年 | 24篇 |
1987年 | 18篇 |
1986年 | 15篇 |
1985年 | 18篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 13篇 |
1981年 | 13篇 |
1979年 | 16篇 |
1977年 | 13篇 |
1974年 | 10篇 |
1973年 | 10篇 |
1971年 | 10篇 |
1968年 | 11篇 |
1967年 | 10篇 |
排序方式: 共有2185条查询结果,搜索用时 328 毫秒
41.
42.
Identification of novel CYP1B1 gene mutations in patients with primary congenital and primary open‐angle glaucoma 下载免费PDF全文
43.
Appadurai Daniel Reegan Munusamy Rajiv Gandhi Micheal Gabriel Paulraj Savarimuthu Ignacimuthu 《Osong Public Health and Research Perspectives》2015,6(1):64-69
Objectives
To evaluate the ovicidal and oviposition deterrent activities of five medicinal plant extracts namely Aegle marmelos (Linn.), Limonia acidissima (Linn.), Sphaeranthus indicus (Linn.), Sphaeranthus amaranthoides (burm.f), and Chromolaena odorata (Linn.) against Culex quinquefasciatus and Aedes aegypti mosquitoes. Three solvents, namely hexane, ethyl acetate, and methanol, were used for the preparation of extracts from each plant.Methods
Four different concentrations—62.5 parts per million (ppm), 125 ppm, 250 ppm, and 500 ppm—were prepared using acetone and tested for ovicidal and oviposition deterrent activities. One-way analysis of variance (ANOVA) was used to determine the significance of the treatments and means were separated by Tukey''s test of comparison.Results
Among the different extracts of the five plants screened, the hexane extract of L. acidissima recorded the highest ovicidal activity of 79.2% and 60% at 500 ppm concentration against the eggs of Cx. quinquefasciatus and Ae. aegypti, respectively. Similarly, the same hexane extract of L. acidissima showed 100% oviposition deterrent activity at all the tested concentrations against Cx. quinquefasciatus and Ae. aegypti adult females.Conclusion
It is concluded that the hexane extract of L. acidissima could be used in an integrated mosquito management program. 相似文献44.
45.
46.
47.
Mark Ashworth Peter Schofield Stevo Durbaba Sanjiv Ahluwalia 《The British journal of general practice》2014,64(620):e168-e177
Background
Quality indicators for primary care focus predominantly on the public health model and organisational measures. Patient experience is an important dimension of quality. Accreditation for GP training practices requires demonstration of a series of attributes including patient-centred care.Aim
The national GP Patient Survey (GPPS) was used to determine the characteristics of general practices scoring highly in responses relating to the professional skills and characteristics of doctors. Specifically, to determine whether active participation in postgraduate GP training was associated with more positive experiences of care.Design and setting
Retrospective cross-sectional study in general practices in England.Method
Data were obtained from the national QOF dataset for England, 2011/12 (8164 general practices); the GPPS in 2012 (2.7 million questionnaires in England; response rate 36%); general practice and demographic characteristics. Sensitivity analyses included local data validated by practice inspections. Outcome measures: multilevel regression models adjusted for clustering.Results
GP training practice status (29% of practices) was a significant predictor of positive GPPS responses to all questions in the ‘doctor care’ (n = 6) and ‘overall satisfaction’ (n = 2) domains but not to any of the ‘nurse care’ or ‘out-of-hours’ domain questions. The findings were supported by the sensitivity analyses. Other positive determinants were: smaller practice and individual GP list sizes, more older patients, lower social deprivation and fewer ethnic minority patients.Conclusion
Based on GPPS responses, doctors in GP training practices appeared to offer more patient-centred care with patients reporting more positively on attributes of doctors such as ‘listening’ or ‘care and concern’. 相似文献48.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. It is associated with a poor prognosis and has limited treatment options. Sorafenib, a multi-targeted kinase inhibitor, is the only available systemic agent for treatment of HCC that improves overall survival for patients with advanced stage disease; unfortunately, an effective second-line agent for the treatment of progressive or sorafenib-resistant HCC has yet to be identified. This review focuses on components of the mammalian target of rapamycin (mTOR) pathway, its role in HCC pathogenesis, and dual mTOR inhibition as a therapeutic option with potential efficacy in advanced HCC. There are several important upstream and downstream signals in the mTOR pathway, and alternative tumor-promoting pathways are known to exist beyond mTORC1 inhibition in HCC. This review analyzes the relationships of the upstream and downstream regulators of mTORC1 and mTORC2 signaling; it also provides a comprehensive global picture of the interaction between mTORC1 and mTORC2 which demonstrates the pre-clinical relevance of the mTOR pathway in HCC pathogenesis and progression. Finally, it provides scientific rationale for dual mTORC1 and mTORC2 inhibition in the treatment of HCC. Clinical trials utilizing mTORC1 inhibitors and dual mTOR inhibitors in HCC are discussed as well. The mTOR pathway is comprised of two main components, mTORC1 and mTORC2; each has a unique role in the pathogenesis and progression of HCC. In phase III studies, mTORC1 inhibitors demonstrate anti-tumor activity in advanced HCC, but dual mTOR (mTORC1 and mTORC2) inhibition has greater therapeutic potential in HCC treatment which warrants further clinical investigation. 相似文献
49.